HomeNewsGlobal Pharma

Strides Gets Approval from Equity Shareholders for Launch of OneSource

Strides Gets Approval from Equity Shareholders for Launch of OneSource

Strides Pharma Science Ltd. has bagged the approval of its equity shareholders and secured creditors with an overwhelming majority, along with those of OneSource Specialty Pharma Limited and SteriScience Specialties Pvt. Ltd., in meetings convened under the guidance of the National Company Law Tribunal (NCLT). 

All the secured creditors who voted on the scheme for the three companies in their respective meetings, were in favour of the Scheme.

This is a critical step in the creation of OneSource and the support from shareholders and secured creditors underscores the confidence in the company’s strategic initiative to create OneSource - India’s first specialty pharma Contract Development and Manufacturing Organization (CDMO) covering advanced sectors like biologics, complex injectables, and oral technologies, including soft-gelatin capsules.

In September 2023, Strides announced its strategic initiative to create OneSource as an independent specialty pharmaceutical CDMO by integrating the Oral Technologies (Soft Gelatin Capsules) business from Strides, Sterile Injectables business of SteriScience Specialty Private Limited and the Biologics and high-end drug devices combination business of OneSource (erstwhile Stelis).

Having already received Stock Exchange approvals in May 2024, this latest approval from Equity Shareholders and Secured Creditors marks a significant milestone. The company will now seek final approval from the Hon'ble NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE.

Commenting on the development, Arun Kumar, Executive Chairperson, and Badree Komandur, Managing Director and Group CEO, Strides, stated, “We are pleased to have received the strong backing from our shareholders and secured creditors for the creation of OneSource. We believe OneSource will unlock considerable value for Strides' stakeholders upon its listing. We remain committed to delivering on this promise and express our gratitude to our shareholders and creditors for their continued trust and support.”

More news about: global pharma | Published by Aishwarya | September - 11 - 2024 | 264

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members